Status:
COMPLETED
LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
Breast Cancer Research Foundation
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
70+ years
Brief Summary
This study recruits woman over the age of 70 who have completed primary treatment for early breast cancer in the last 2 months. A survey called the geriatric assessment will be used to identify sympto...
Detailed Description
1\. Primary Objective Estimate the percent of patients with at least one deficit who agree to at least one referral. "Interest" in the intervention will be determined by this metric. This agreement wi...
Eligibility Criteria
Inclusion
- Women aged 70 or older
- within 6 months of complete primary treatment (surgery, chemotherapy, targeted therapy, or radiation) for breast cancer (Stage I-III)
- Able to read English
- Willing and capable of providing informed consent
Exclusion
- Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rendering of informed consent.
Key Trial Info
Start Date :
March 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04292847
Start Date
March 12 2020
End Date
May 20 2024
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599